Stocks Health care TLSI
NASDAQ · Health careTriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc. brought in $45.1M of revenue over the twelve months to June 30, 2026, up 25.2% from a year earlier. It posted a net loss of $28.2M. In fiscal 2025 capital spending exceeded operating cash flow by $18.9M. At June 30, 2026 it held $46.3M in cash against $33.1M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What TriSalus Life Sciences, Inc. does
TriSalus Life Sciences, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker TLSI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $45.2M | -$39.2M | -$1.84 | -$18.9M |
| 2024 | $29.4M | -$30M | -$1.31 | -$41.2M |
| 2023 | $18.5M | -$59.4M | -$6.77 | -$51.2M |
| 2022 | $12.4M | -$47.2M | -$161.55 | -$33M |
| 2021 | n/a | $4.8M | n/a | n/a |
Latest SEC filings
What TriSalus Life Sciences, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 22, 2026Other event 8-K
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 7, 2026Passive stake changed SCHEDULE 13G/A
- May 20, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 14, 2026
- May 12, 2026Quarterly report 10-Q · period to March 31, 2026
- May 12, 2026
- May 12, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about TLSI
What does TriSalus Life Sciences, Inc. do?
TriSalus Life Sciences, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker TLSI.
Is TriSalus Life Sciences, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $28.2M on revenue of $45.1M.
How much revenue does TriSalus Life Sciences, Inc. make?
Over the twelve months to June 30, 2026 TriSalus Life Sciences, Inc. reported revenue of $45.1M. That is 25.2% more than a year earlier.
When did TriSalus Life Sciences, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 22, 2026.
Similar companies
Follow TLSI
Get an email when TriSalus Life Sciences, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow TLSI: get an email when it filesWhere the numbers come from
Financial figures are the values TriSalus Life Sciences, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.